Dr. Boyle receives a NCI R21. This 3-year award focuses on technology development around identifying silencer elements in cancers as part of the broader NCI-sponsored Innovative Molecular Analysis Technologies (IMAT) Program.
Dr. Boyle receives NCI R21 IMAT award!
Award details
Project information
- Agency
- National Cancer Institute
- Mechanism
- R21 IMAT
- Project
- High-throughput inverted reporter assay for characterization of silencers and enhancer blockers
More from the lab
